Invesaro

Stocks Health care EIKN

NASDAQ · Health care

Eikon Therapeutics, Inc. (EIKN)

At June 30, 2026 it held $142.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

What Eikon Therapeutics, Inc. does

Eikon Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker EIKN.

Next report expected around October 20, 2026.

Estimated from its filing rhythm: about 68 days after its last report of August 13, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Eikon Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
    Investor disclosure 8-K
  2. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026
  3. August 13, 2026
    Quarterly results 8-K
  4. August 6, 2026
    Passive stake changed SCHEDULE 13G/A
  5. August 3, 2026
    Executive or director change 8-K
  6. June 10, 2026
    Executive or director change 8-K
  7. June 1, 2026
    Investor disclosure 8-K
  8. May 15, 2026
    Passive stake (5% or more) SCHEDULE 13G
  9. May 13, 2026
    Passive stake (5% or more) SCHEDULE 13G
  10. May 11, 2026
    Quarterly report 10-Q · period to March 31, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 8, 2026. Insider transactions on SEC

Insider trades

What the people running Eikon Therapeutics, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $1M worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$1M
last 90 days
Sold
$0
last 90 days
Net bought
89,200
$1M
DateInsiderWhatSharesPriceValueFiling
September 3, 2026 Column Group IV GP, LP10% owner Boughtindirect 89,200 $11.56 $1M Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about EIKN

What does Eikon Therapeutics, Inc. do?

Eikon Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker EIKN.

When did Eikon Therapeutics, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 8, 2026.

Similar companies

AMGN
Amgen Inc
GILD
Gilead Sciences, Inc.
BIIB
Biogen Inc.
BNTX
BioNTech SE
NBIX
Neurocrine Biosciences Inc
EXEL
Exelixis, Inc.

Compare EIKN with

Compare EIKN with any company

Follow EIKN

Get an email when Eikon Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow EIKN: get an email when it files

Where the numbers come from

Financial figures are the values Eikon Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.